Adial Pharmaceuticals
(NASDAQ) ADIL
Adial Pharmaceuticals Financials at a Glance
Market Cap
$2.86M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.98M
EPS (TTM)
$-16.95
P/E Ratio
-0.12
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$1.98
Volume
177,909
Open
$1.91
Price
$1.98
Volume
177,909
Open
$1.91
Previous Close
$2.00
Daily Range
$1.90 - $2.08
52-Week Range
$1.54 - $30.25
Dividend
$0.00
Beta (Volatility)
0.76 (Low)
Price
$1.98
Volume
177,909
Open
$1.91
Previous Close
$2.00
Daily Range
$1.90 - $2.08
52-Week Range
$1.54 - $30.25
ADIL News
ADIL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adial Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
6
CEO
Cary J. Claiborne, MBA
Website
www.adial.comHeadquarters
Charlottesville, VA 22901, US
ADIL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-171%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-8.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.86M
Shares Outstanding
1.43M
Volume
177.91K
Short Interest
0.00%
Avg. Volume
76.06K
Financials (TTM)
Gross Profit
$565.00
Operating Income
$7.80M
EBITDA
$7.80M
Operating Cash Flow
$6.49M
Capital Expenditure
$3.00
Free Cash Flow
$6.49M
Cash & ST Invst.
$5.88M
Total Debt
$0.00
Adial Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$142.00
-0.7%
Gross Margin
0.00%
N/A
Market Cap
$2.86M
N/A
Market Cap/Employee
$571.18K
N/A
Employees
5
N/A
Net Income
$2.00M
+3.6%
EBITDA
$1.89M
+9.0%
Quarterly Fundamentals
Net Cash
$5.88M
+56.8%
Accounts Receivable
$41.76K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.17%
N/A
Return on Invested Capital
-1.44%
N/A
Free Cash Flow
$1.32M
+8.9%
Operating Cash Flow
$1.32M
+8.9%